Perinatal Outcomes in Type 2 Diabetes

被引:0
|
作者
Niranjala M. Hewapathirana
Helen R. Murphy
机构
[1] Nottingham University Hospitals NHS Trust,MRCP, Queens Medical Centre
[2] University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Center,Level 4 Metabolic Research Laboratories
[3] Institute of Metabolic Science,undefined
来源
Current Diabetes Reports | 2014年 / 14卷
关键词
Congenital malformation (CM); Large for gestational age (LGA); Macrosomia; Perinatal mortality (PNM); Stillbirth (SB); Neonatal mortality (NM); Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
Over the past decade the prevalence of type 2 diabetes in pregnancy has continued to increase. It is vital that health care professionals recognize that preconception care is just as important for mothers with type 2 diabetes as it is in type 1 diabetes. All women with type 2 diabetes should be advised regarding safe effective contraception and the benefits of optimal glycemic control, folic acid supplementation, and avoidance of potentially harmful mediations before attempting pregnancy. Glycemic control is the most important modifiable risk factor for congenital anomaly in women with type 2 diabetes, whereas maternal obesity and social disadvantage are associated with large for gestational age neonates. This review aims to bring the reader up to date with the burden of perinatal outcomes and clinical interventions to improve maternal and infant health. It warns that the consequences of type 2 diabetes pregnancy do not end at birth.
引用
收藏
相关论文
共 50 条
  • [21] A Medical Nutrition Therapy Program Improves Perinatal Outcomes in Mexican Pregnant Women With Gestational Diabetes and Type 2 Diabetes Mellitus
    Perichart-Perera, Otilia
    Balas-Nakash, Margie
    Parra-Covarrubias, Adalberto
    Rodriguez-Cano, Ameyalli
    Ramirez-Torres, Aurora
    Ortega-Gonzalez, Carlos
    Vadillo-Ortega, Felipe
    DIABETES EDUCATOR, 2009, 35 (06): : 1004 - 1013
  • [22] Health outcomes in type 2 diabetes
    Reddy, SSK
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 46 - 53
  • [23] Microvascular outcomes in type 2 diabetes
    Stehouwer, Coen D. A.
    van Sloten, Thomas T.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08): : 579 - 579
  • [24] Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantage
    Murphy, H. R.
    Steel, S. A.
    Roland, J. M.
    Morris, D.
    Ball, V.
    Campbell, P. J.
    Temple, R. C.
    DIABETIC MEDICINE, 2011, 28 (09) : 1060 - 1067
  • [25] Diabetes Medications and Cardiovascular Outcomes in Type 2 Diabetes
    Chi, Cecilia
    Snaith, Jennifer
    Gunton, Jenny E.
    HEART LUNG AND CIRCULATION, 2017, 26 (11): : 1133 - 1141
  • [26] Short and sweet: the perinatal origins of type 2 diabetes mellitus
    Cutfield, W
    PEDIATRIC DIABETES, 2004, 5 (03) : 113 - 116
  • [27] Effect of gestational weight loss on perinatal outcomes in overweight and obese women with gestational and type 2 diabetes mellitus
    Caughey, Aaron B.
    Yee, Lynn M.
    Cheng, Yvonne W.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S113 - S113
  • [28] Cardiovascular outcomes in type 1 and type 2 diabetes
    Rosengren, Annika
    Dikaiou, Pigi
    DIABETOLOGIA, 2023, 66 (03) : 425 - 437
  • [29] Cardiovascular outcomes in type 1 and type 2 diabetes
    Annika Rosengren
    Pigi Dikaiou
    Diabetologia, 2023, 66 : 425 - 437
  • [30] Trends in maternal characteristics and perinatal outcomes among Japanese pregnant women with type 1 and type 2 diabetes from 1982 to 2020
    Fujikawa Shingu, Kei
    Waguri, Masako
    Takahara, Mitsuyoshi
    Katakami, Naoto
    Shimomura, Iichiro
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (10) : 1761 - 1770